[8-K] Hyperfine, Inc. Reports Material Event

Rhea-AI Filing Summary

Prestige Consumer Healthcare (PBH) – Form 4: Director John E. Byom was granted 2,094 restricted stock units (RSUs) on 08/05/2025 under the company’s director compensation plan. The grant equals $155,000, calculated from the $74.04 closing price. RSUs vest in one year and convert to one common share each upon the earliest of the director’s death, separation, or a change in control.

No shares were sold; the transaction is coded “A” (acquisition) at $0 cost, confirming it is a non-open-market award. Byom’s direct ownership increases to 54,594 PBH shares.

The filing reflects routine board compensation, adds marginal equity alignment, and has negligible dilution or valuation impact for investors.

Positive

• Director acquired 2,094 RSUs, increasing equity alignment with shareholders

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine RSU grant; minimal dilution; neutral valuation impact; slightly tighter director-shareholder alignment.

The 2,094-unit RSU grant, worth $155k, is standard annual compensation. No cash outlay or open-market purchase occurred, so liquidity and market sentiment remain unchanged. Post-grant ownership of 54,594 shares modestly increases insider exposure but is immaterial relative to PBH’s total float. Because the award vests in 12 months and settles only upon separation or other triggers, near-term share count effects are negligible. Overall, the filing is operationally neutral and should not influence valuation or trading dynamics.

false000183376900018337692025-08-062025-08-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 06, 2025

Hyperfine, Inc.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-39949	98-1569027
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
351 New Whitfield Street
Guilford, Connecticut				06437
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: (866) 796-6767

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Class A common stock, $0.0001 par value per share		HYPR		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events.

As previously reported, on April 30, 2025, Hyperfine, Inc. (the “Company”) received written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), had fallen below $1.00 per share for 30 consecutive business days, the Company no longer met the minimum bid price requirement for continued inclusion on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”).

On August 6, 2025, the Company received a letter from the Staff of Nasdaq indicating that it has regained compliance with the Bid Price Requirement and this matter is now closed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			HYPERFINE, INC.
Date:	August 6, 2025	By:	/s/ Brett Hale
			Brett Hale Chief Administrative Officer, Chief Financial Officer, Treasurer and Corporate Secretary

FAQ

What insider transaction did PBH report on Form 4?

Director John E. Byom received 2,094 restricted stock units valued at $155,000 on 08/05/2025.

How many Prestige Consumer Healthcare shares does John E. Byom now own?

After the grant, the director directly owns 54,594 common shares of PBH.

When do the newly granted PBH RSUs vest?

The RSUs vest on the first anniversary of the 08/05/2025 grant date.

Was the PBH insider transaction an open-market purchase?

No. The Form 4 lists the code “A” at $0 cost, indicating a compensatory grant, not a market buy.

Did the filing disclose any share sales by the director?

No share sales were reported; the filing shows only an acquisition of RSUs.